# TREVI THERAPEUTICS INC (TRVI)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TRVI/

- Reporting holders: 5
- Reported value: $430.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CHAPIN DAVIS, INC.](https://holderbook.com/funds/872098-chapin-davis-inc/) | $287.8K | 20,100 | 0.1% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $132.1K | 9,226 | 0.0% | 11 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $7.4K | 516 | 0.0% | 6 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.8K | 193 | 0.0% | 7 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $258 | 18 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $430.4K |
| Q2 2026 | 224 | $2.9B |
| Q1 2026 | 198 | $1.6B |
| Q4 2025 | 185 | $1.6B |
| Q3 2025 | 167 | $1.2B |
| Q2 2025 | 158 | $643.2M |
| Q1 2025 | 141 | $568.4M |
| Q4 2024 | 109 | $331.6M |
| Q3 2024 | 92 | $195.0M |
| Q2 2024 | 77 | $175.1M |
| Q1 2024 | 79 | $178.5M |
| Q4 2023 | 63 | $70.2M |